Clinical Trial Update: Satraplatin and Prednisone to Treat Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating satraplatin plus prednisone for prostate cancer has completed; results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• PREDNISONE (Prednisone)
• satraplatin (satraplatin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Prostate Cancer, Genetic Polymorphism | Phase 2 | Status: COMPLETED | Results posted: 2013-04-10